{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T18:19:16Z","timestamp":1759342756143},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2020,4,6]],"date-time":"2020-04-06T00:00:00Z","timestamp":1586131200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,4,6]],"date-time":"2020-04-06T00:00:00Z","timestamp":1586131200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hautarzt"],"published-print":{"date-parts":[[2020,5]]},"DOI":"10.1007\/s00105-020-04579-2","type":"journal-article","created":{"date-parts":[[2020,4,6]],"date-time":"2020-04-06T10:02:46Z","timestamp":1586167366000},"page":"359-364","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Autoinflammatorische Dermatosen"],"prefix":"10.1007","volume":"71","author":[{"given":"J.","family":"Ehrchen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Drerup","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,4,6]]},"reference":[{"key":"4579_CR1","doi-asserted-by":"publisher","first-page":"1511","DOI":"10.1016\/S0140-6736(14)62447-8","volume":"385","author":"CA Blum","year":"2015","unstructured":"Blum\u00a0CA, Nigro\u00a0N, Briel\u00a0M et al (2015) Adjunct prednisone therapy for patients with community-acquired pneumonia: a\u00a0multicentre, double-blind, randomised, placebo-controlled trial. Lancet 385:1511\u20131518","journal-title":"Lancet"},{"key":"4579_CR2","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1111\/bjh.14144","volume":"174","author":"E Brisse","year":"2016","unstructured":"Brisse\u00a0E, Matthys\u00a0P, Wouters\u00a0CH (2016) Understanding the spectrum of haemophagocytic lymphohistiocytosis: update on diagnostic challenges and therapeutic options. Br J Haematol 174:175\u2013187","journal-title":"Br J Haematol"},{"key":"4579_CR3","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1097\/DAD.0000000000000390","volume":"38","author":"SM Broekaert","year":"2016","unstructured":"Broekaert\u00a0SM, Boer-Auer\u00a0A, Kerl\u00a0K et al (2016) Neutrophilic epitheliotropism is a\u00a0histopathological clue to neutrophilic urticarial dermatosis. Am J Dermatopathol 38:39\u201349","journal-title":"Am J Dermatopathol"},{"key":"4579_CR4","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1186\/s13075-019-2021-9","volume":"21","author":"S Colafrancesco","year":"2019","unstructured":"Colafrancesco\u00a0S, Manara\u00a0M, Bortoluzzi\u00a0A et al (2019) Management of adult-onset Still\u2019s disease with interleukin\u20111 inhibitors: evidence- and consensus-based statements by a\u00a0panel of Italian experts. Arthritis Res Ther 21:275","journal-title":"Arthritis Res Ther"},{"key":"4579_CR5","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1111\/bjd.15896","volume":"178","author":"B Dasgeb","year":"2018","unstructured":"Dasgeb\u00a0B, Kornreich\u00a0D, Mcguinn\u00a0K et\u00a0al (2018) Colchicine: an ancient drug with novel applications. Br J Dermatol 178:350\u2013356","journal-title":"Br J Dermatol"},{"key":"4579_CR6","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1146\/annurev-immunol-032414-112227","volume":"33","author":"AA de Jesus","year":"2015","unstructured":"de Jesus\u00a0AA, Canna\u00a0SW, Liu\u00a0Y et\u00a0al (2015) Molecular mechanisms in genetically defined autoinflammatory diseases: disorders of amplified danger signaling. Annu Rev Immunol 33:823\u2013874","journal-title":"Annu Rev Immunol"},{"key":"4579_CR7","doi-asserted-by":"publisher","first-page":"R139","DOI":"10.1186\/ar3453","volume":"13","author":"WG Dixon","year":"2011","unstructured":"Dixon\u00a0WG, Suissa\u00a0S, Hudson\u00a0M (2011) The association between systemic glucocorticoid therapy and the risk of infection in patients with rheumatoid arthritis: systematic review and meta-analyses. Arthritis Res Ther 13:R139","journal-title":"Arthritis Res Ther"},{"key":"4579_CR8","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1007\/s00105-018-4353-9","volume":"70","author":"C Drerup","year":"2019","unstructured":"Drerup\u00a0C, Ehrchen\u00a0J (2019) Raynaud\u2019s phenomenon : practical management for dermatologists. Hautarzt 70:131\u2013141","journal-title":"Hautarzt"},{"key":"4579_CR9","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.ejim.2009.11.006","volume":"21","author":"SP Efstathiou","year":"2010","unstructured":"Efstathiou\u00a0SP, Pefanis\u00a0AV, Tsiakou\u00a0AG et al (2010) Fever of unknown origin: discrimination between infectious and non-infectious causes. Eur J Intern Med 21:137\u2013143","journal-title":"Eur J Intern Med"},{"key":"4579_CR10","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1007\/s00105-016-3788-0","volume":"67","author":"J Ehrchen","year":"2016","unstructured":"Ehrchen\u00a0J (2016) Neurophilic urticarial dermatosis. Hautarzt 67:403\u2013413","journal-title":"Hautarzt"},{"key":"4579_CR11","doi-asserted-by":"publisher","first-page":"2028","DOI":"10.3389\/fimmu.2019.02028","volume":"10","author":"JM Ehrchen","year":"2019","unstructured":"Ehrchen\u00a0JM, Roth\u00a0J, Barczyk-Kahlert\u00a0K (2019) More than suppression: glucocorticoid action on monocytes and macrophages. Front Immunol 10:2028","journal-title":"Front Immunol"},{"key":"4579_CR12","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.15984","author":"L Gusdorf","year":"2019","unstructured":"Gusdorf\u00a0L, Lipsker\u00a0D (2019) Neutrophilic urticarial dermatosis: an entity bridging monogenic and polygenic autoinflammatory disorders, and beyond. J\u00a0Eur Acad Dermatol Venereol. https:\/\/doi.org\/10.1111\/jdv.15984","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"4579_CR13","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1111\/bjd.12548","volume":"170","author":"U Huffmeier","year":"2014","unstructured":"Huffmeier\u00a0U, Watzold\u00a0M, Mohr\u00a0J et\u00a0al (2014) Successful therapy with anakinra in a\u00a0patient with generalized pustular psoriasis carrying IL36RN mutations. Br J Dermatol 170:202\u2013204","journal-title":"Br J Dermatol"},{"key":"4579_CR14","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1155\/2013\/915389","volume":"34","author":"SE Kim","year":"2013","unstructured":"Kim\u00a0SE, Kim\u00a0UJ, Jang\u00a0MO et\u00a0al (2013) Diagnostic use of serum ferritin levels to differentiate infectious and noninfectious diseases in patients with fever of unknown origin. Dis Markers 34:211\u2013218","journal-title":"Dis Markers"},{"key":"4579_CR15","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1159\/000079897","volume":"209","author":"GJ Kontochristopoulos","year":"2004","unstructured":"Kontochristopoulos\u00a0GJ, Stavropoulos\u00a0PG, Gregoriou\u00a0S et al (2004) Treatment of pyoderma gangrenosum with low-dose colchicine. Dermatology 209:233\u2013236","journal-title":"Dermatology"},{"key":"4579_CR16","doi-asserted-by":"publisher","first-page":"1465","DOI":"10.1111\/j.1398-9995.2012.02843.x","volume":"67","author":"K Krause","year":"2012","unstructured":"Krause\u00a0K, Grattan\u00a0CE, Bindslev-Jensen\u00a0C et al (2012) How not to miss autoinflammatory diseases masquerading as urticaria. Allergy 67:1465\u20131474","journal-title":"Allergy"},{"key":"4579_CR17","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.1016\/j.jaci.2016.07.041","volume":"139","author":"K Krause","year":"2017","unstructured":"Krause\u00a0K, Tsianakas\u00a0A, Wagner\u00a0N et al (2017) Efficacy and safety of canakinumab in Schnitzler syndrome: a multicenter randomized placebo-controlled study. J\u00a0Allergy Clin Immunol 139:1311\u20131320","journal-title":"J Allergy Clin Immunol"},{"key":"4579_CR18","doi-asserted-by":"publisher","first-page":"378","DOI":"10.7883\/yoken.JJID.2015.470","volume":"69","author":"CP Liu","year":"2016","unstructured":"Liu\u00a0CP, Liu\u00a0ZY, Liu\u00a0JP et\u00a0al (2016) Diagnostic value of common inflammatory markers on fever of unknown origin. Jpn J Infect Dis 69:378\u2013383","journal-title":"Jpn J Infect Dis"},{"key":"4579_CR19","doi-asserted-by":"publisher","first-page":"1588","DOI":"10.1111\/bjd.15226","volume":"176","author":"AV Marzano","year":"2017","unstructured":"Marzano\u00a0AV, Damiani\u00a0G, Ceccherini\u00a0I et\u00a0al (2017) Autoinflammation in pyoderma gangrenosum and its syndromic form (pyoderma gangrenosum, acne and suppurative hidradenitis). Br J Dermatol 176:1588\u20131598","journal-title":"Br J Dermatol"},{"key":"4579_CR20","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1111\/all.12129","volume":"68","author":"A Simon","year":"2013","unstructured":"Simon\u00a0A, Asli\u00a0B, Braun-Falco\u00a0M et al (2013) Schnitzler\u2019s syndrome: diagnosis, treatment, and follow-up. Allergy 68:562\u2013568","journal-title":"Allergy"},{"key":"4579_CR21","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1111\/bjd.14685","volume":"176","author":"P Skendros","year":"2017","unstructured":"Skendros\u00a0P, Papagoras\u00a0C, Lefaki\u00a0I et al (2017) Successful response in a\u00a0case of severe pustular psoriasis after interleukin-1beta inhibition. Br J Dermatol 176:212\u2013215","journal-title":"Br J Dermatol"},{"key":"4579_CR22","doi-asserted-by":"publisher","DOI":"10.1007\/s40257-019-00492-0","author":"T Takeichi","year":"2019","unstructured":"Takeichi\u00a0T, Akiyama\u00a0M (2019) Generalized pustular psoriasis: clinical management and update on autoinflammatory aspects. Am J Clin Dermatol. https:\/\/doi.org\/10.1007\/s40257-019-00492-0","journal-title":"Am J Clin Dermatol"},{"key":"4579_CR23","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1111\/ijd.13603","volume":"56","author":"C Vinkel","year":"2017","unstructured":"Vinkel\u00a0C, Thomsen\u00a0SF (2017) Autoinflammatory syndromes associated with hidradenitis suppurativa and\/or acne. Int J Dermatol 56:811\u2013818","journal-title":"Int J Dermatol"},{"key":"4579_CR24","doi-asserted-by":"publisher","first-page":"e11149","DOI":"10.1097\/MD.0000000000011149","volume":"97","author":"Q Yang","year":"2018","unstructured":"Yang\u00a0Q, Zhao\u00a0Y, Li\u00a0C et\u00a0al (2018) Case report: successful treatment of refractory SAPHO syndrome with the JAK inhibitor tofacitinib. Medicine 97:e11149","journal-title":"Medicine"}],"container-title":["Der Hautarzt"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00105-020-04579-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00105-020-04579-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00105-020-04579-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,5]],"date-time":"2021-04-05T23:09:54Z","timestamp":1617664194000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00105-020-04579-2"}},"subtitle":["Diagnostik und Therapie"],"short-title":[],"issued":{"date-parts":[[2020,4,6]]},"references-count":24,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2020,5]]}},"alternative-id":["4579"],"URL":"https:\/\/doi.org\/10.1007\/s00105-020-04579-2","relation":{},"ISSN":["0017-8470","1432-1173"],"issn-type":[{"value":"0017-8470","type":"print"},{"value":"1432-1173","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,4,6]]},"assertion":[{"value":"6 April 2020","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"J.\u00a0Ehrchen war als Referent f\u00fcr die Firma Sobi, Novartis, Pfizer, Chugai, Mylan und Janssen t\u00e4tig und erhielt ein Beraterhonorar von der Firma Sobi, Novartis und Boehringer Ingelheim. C.\u00a0Drerup gibt an, dass kein Interessenkonflikt besteht.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"F\u00fcr diesen Beitrag wurden von den Autoren keine Studien an Menschen oder Tieren durchgef\u00fchrt. F\u00fcr die aufgef\u00fchrten Studien gelten die jeweils dort angegebenen ethischen Richtlinien. F\u00fcr Bildmaterial oder anderweitige Angaben innerhalb des Manuskripts, \u00fcber die Patienten zu identifizieren sind, liegt von ihnen und\/oder ihren gesetzlichen Vertretern eine schriftliche Einwilligung vor.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}}]}}